[
Galderma's Nemluvio ® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
[og_img]
https://www.investing.com/news/press-releases/galdermas-nemluvio–nemolizumab-approved-in-the-european-union-for-moderatetosevere-atopic-dermatitis-and-prurigo-nodularis-93CH-3869620
Investing.com
Galderma's Nemluvio ® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Related articles
